euroPLX 46 Vienna

Registration Fee and Conditions

Delegates' Comments

"…four times as much for half the price…"
Anke Rau and Dr. Norbert Rau

"euroPLX is sometimes tough and intense…"
Sebastien Sanial and Malgorzata Derewianka

"…a very efficient way to meet in one-to-one meetings…"
Dr. Peter Komnick and Dr. Silke Behne

"We are Platinum Sponsors of euroPLX 49 Istanbul, because…"
Rich DiCicco

"We became a returning attendee as we've never left empty-handed…"
Kees Trommelen

"…get focused on the business...just business!"
Dragan Lutz and Mario Vlasic

"I have successfully used the euroPLX meetings for licensing-in and licensing-out…"
Dr. Satyendra Kumar

"…meet your business partners at the well organized events…"
Peter van Hoogstraten and Paul C. Borghouts

"…a highly effective and pleasant way to meet…"
Ronald Kriek and Wouter Hanegraaf

"…interact with so many companies…"
Simona Aganovic and Guy Clark

"We get value for our money…"
Vilas Nagare and Sundeep V. Bambolkar

"It’s the best partnering event…"
Jinang Parekh and Vijay Agarwal

"…the only partnering conference that covers all aspects of business development…"
Dr. Hubert Ridolphi and Dr. Gerrit Hagens

"…no better event than euroPLX to enlarge your network in the
pharmaceutical business…"
Gilbert Adatte

"...good place to expand your international network..."
Ramon Brusco

"…we wouldn’t do that if there were no results!"
Patrick Tichy

"…one of the few events which attracts a cross section of attendees from all pharmaceutical sectors…"
Daniel Jones

"…the best time and cost effective way to meet new partners."
Nuray Acar and Mutlu Topal

"There is no end to new challenges at euroPLX"
Ruud Koolen

"…a basis for excellent business."
Ana Paula Branco and José Roberto Pereira

"euroPLX is the most cost-effective and time-saving way…"
David Zubeldía

"…good opportunity for meeting with many relevant players…"
Dietmar Jannaschk and Gemma Mogas

"…euroPLX is the perfect place…"
Gustavo Samojeden and Hernán Bouzada

"…a tremendous opportunity to meet new partners…"
Marc Alvarez

"…efficient and fruitful one-to-one discussions…"
Sylvie Fondanayche

"We are not aware of any other event where you can meet so many interesting partners…"
Holger and Kai Schleenhain

"I rate euroPLX very high…"
Reynhardt Van As

"euroPLX is the best pharma meeting…"
Santiago, Mar, and Josémaria Calzada

"…very good opportunity to meet existing and new business partners…"
Agnes Olszanowski and Dr. Marian Takac

"I never leave euroPLX empty-handed."
Wendell Clayton

"…the best possible way to contact a large number of people…" Shala Fardaei and Ineke Braat

"It was in this forum that we forged some of our major alliances…" Nimit Jhaveri and Biplab Kar

"…we have made a lot of money on euroPLX deals…"
Rich DiCicco

"…an ideal opportunity to meet…"
Andreas Wagner & Michel Blanc

"…extremely time and cost efficient way to make new business contacts…"
Wolfgang Bäurle

"euroPLX is the most efficient event I know…"
Patsy Carney

"…the most efficient of the Business Development forums…"
Roland Brown

"…a tremendous opportunity to network intensely…"
Elzbieta Weston & Jacek Plucienniczak

Sponsors for euroPLX 46 Vienna

Media Sponsors

One of the Most International Partnering Events!

euroPLX 46 Vienna

More than 140 pharma and biopharma companies from 40 countries!

Click to view registered companies

euroPLX 46 Vienna was attended by delegates of more than 140 pharmaceutical companies from a record number of 40 countries and five continents. It took place on May 30 + 31, 2011 in Vienna, Austria.

The leading partnering event for pharma and biopharma business development delivered an average of almost 24 pre-scheduled one-on-one negotiations per participating company on two conference days, in addition to numerous appointments which were scheduled on site.

Contrary to euroPLX 45 Lisbon which had a bias for disorders of the central nervous system, the delegates' interests at euroPLX 46 Vienna were more evenly distributed over all therapeutic areas with neurology, cardiovascular diseases, pain, and gastroenterological disorders having been of interest for more than 70% of the delegates.